Boral has won its bid to shield from shareholders in a class action three investigative reports, including one by accounting giant EY, concerning financial irregularities in the construction company’s North America windows business.
The Australian Competition and Consumer Commission has brought proceedings against Telstra alleging it misled almost 9,000 customers about the upload speed of its budget internet provider Belong.
A judge has rejected barrister Gina Edwards’ “somewhat speculative” bid to issue interrogatories to Nine, weeks out from trial in a defamation case brought over the media company’s coverage of her custody battle for famed social media pooch Oscar the cavoodle.
Aluminium giant Alcoa has sued AusNet and Powercor over a 2016 power outage that left the future of its Victorian smelter site in doubt.
A contradictor in two pelvic mesh class actions against Johnson & Johnson has opposed Shine Lawyers recovering $100 million in costs from a $300 million settlement, which a judge has preliminarily found is not fair and reasonable to group members.
Trial in the battle of the buns has begun, with McDonald’s laying out a case for why its rival’s Big Jack burger infringes its trade mark, and Hungry Jack’s firing back that consumers could not confuse its flame-grilled meal with the iconic Big Mac.
A litigation funder has abandoned its case seeking to prevent counsel retained by the lead applicant in the settled Montara oil spill class action from providing independent legal advice.
Former defence minister Linda Reynolds is facing a civil suit by former staffer Brittany Higgins in relation to her alleged rape inside Reynold’s Parliament House office in 2019.
Westpac has lost a bid to keep group members in the dark about the premiums paid for allegedly worthless consumer credit insurance, information the bank said could inflate expectations about settlements worth $126 million reached in three class actions.
Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge by Australian drug maker Generic Partners.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
